Conmed (CNMD) Long-Term Deferred Tax (2010 - 2025)
Conmed's (CNMD) quarterly Long-Term Deferred Tax came in at $13.3 million in Q4 2025, up 20.24% on a YoY basis from $11.1 million in Q4 2024, and up 20.24% quarter-over-quarter from $11.1 million in Q4 2024.
Analysis
Conmed (CNMD) Long-Term Deferred Tax (2010 - 2025) Analysis & Trends
Conmed (CNMD) has reported Long-Term Deferred Tax for 16 consecutive years, with $13.3 million the latest figure, recorded in Q4 2025.
- For the quarter ending Q4 2025, Long-Term Deferred Tax rose 20.24% year-over-year to $13.3 million; the trailing twelve-month figure through Dec 2025 stood at $13.3 million (up 20.24% YoY), and the FY2025 full-year result was $13.3 million, up 20.24% from the prior year.
- Long-Term Deferred Tax improved to $13.3 million in Q4 2025 per CNMD's latest filing, from $11.1 million in the prior quarter.
- Across five years, Long-Term Deferred Tax topped out at $13.3 million in Q4 2025 and bottomed at $9.6 million in Q4 2022.
- Historically, Long-Term Deferred Tax has averaged $11.0 million across 5 years, with a median of $11.1 million in 2024.
- The sharpest annual moves came in 2021 and 2024: Long-Term Deferred Tax soared 41.14% in 2021, then decreased 1.27% in 2024.
- Over 5 years, Long-Term Deferred Tax stood at $9.7 million in 2021, then decreased by 0.07% to $9.6 million in 2022, then advanced by 16.18% to $11.2 million in 2023, then retreated by 1.27% to $11.1 million in 2024, then advanced by 20.24% to $13.3 million in 2025.
- According to Business Quant data, Long-Term Deferred Tax over the past three periods registered $13.3 million, $11.1 million, and $11.2 million for Q4 2025, Q4 2024, and Q4 2023 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn |
| 10 | Conmed | 1.42 Bn | 1.38 Bn | 197.46 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 13.31 Mn |
| Dec 31, 2024 | 11.07 Mn |
| Dec 31, 2023 | 11.21 Mn |
| Dec 31, 2022 | 9.65 Mn |
| Dec 31, 2021 | 9.66 Mn |
| Dec 31, 2020 | 6.84 Mn |
| Dec 31, 2019 | 5.66 Mn |
| Dec 31, 2018 | 5.16 Mn |
| Dec 31, 2017 | 4.72 Mn |
| Dec 31, 2016 | 3.71 Mn |
| Dec 31, 2015 | 4.24 Mn |
| Sep 30, 2015 | 1.13 Mn |
| Jun 30, 2015 | 1.21 Mn |
| Mar 31, 2015 | 1.19 Mn |
| Dec 31, 2014 | 44.59 Mn |
| Sep 30, 2014 | 1.07 Mn |
| Jun 30, 2014 | 1.15 Mn |
| Mar 31, 2014 | 1.15 Mn |
| Dec 31, 2013 | 33.00 Mn |
| Sep 30, 2013 | 1.18 Mn |